MicroRNA-210 enhances fibrous cap stability in advanced atherosclerotic lesions

Circulation Research

Volumn 120, Issue 4, 2017, Pages 633-644

  Eken, Suzanne M ^a   Jin, Hong ^a   Chernogubova, Ekaterina ^a   Li, Yuhuang ^a   Simon, Nancy ^a   Sun, Changyan ^a   Korzunowicz, Greg ^a   Busch, Albert ^a   Bäcklund, Alexandra ^a   Österholm, Cecilia ^a,b   Razuvaev, Anton ^a   Renné, Thomas ^a,c   Eckstein, Hans Henning ^d   Pelisek, Jaroslav ^d   Eriksson, Per ^a   González Díez, María ^a   Perisic Matic, Ljubica ^a   Schellinger, Isabel N ^e   Raaz, Uwe ^e   Leeper, Nicholas J ^f   Hansson, Göran K ^a   Paulsson Berne, Gabrielle ^a   Hedin, Ulf ^a   Maegdefessel, Lars ^a,d   more..

^a KAROLINSKA INSTITUTE   (Sweden)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f STANFORD UNIVERSITY   (United States)

Author keywords

adenomatous polyposis coli; atherosclerosis; carotid stenosis; microRNAs; stroke

Indexed keywords

MICRORNA 150; MICRORNA 15B; MICRORNA 191; MICRORNA 210; MICRORNA 29C; MICRORNA 30C; MICRORNA 30D; MICRORNA 500; UNCLASSIFIED DRUG; MICRORNA; MIRN210 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COLON POLYPOSIS; CONTROLLED STUDY; DOWN REGULATION; FIBROUS CAP; GENE EXPRESSION; GENE LOCATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; LASER CAPTURE MICRODISSECTION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CELL; TISSUE METABOLISM; TISSUE STRUCTURE; TUMOR SUPPRESSOR GENE; TUMOR SUPPRESSOR GENE APC; VASCULAR REMODELING; WNT SIGNALING PATHWAY; ANIMAL; ATHEROSCLEROSIS; BIOSYNTHESIS; C57BL MOUSE; CAROTID STENOSIS; CELL CULTURE; COHORT ANALYSIS; ENDOTHELIUM CELL; KNOCKOUT MOUSE; METABOLISM; MOUSE; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC; PROCEDURES; SPRAGUE DAWLEY RAT; STROKE;

ANIMALS; ATHEROSCLEROSIS; CAROTID STENOSIS; CELLS, CULTURED; COHORT STUDIES; ENDOTHELIAL CELLS; HUMANS; LASER CAPTURE MICRODISSECTION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; PLAQUE, ATHEROSCLEROTIC; RATS; RATS, SPRAGUE-DAWLEY; STROKE;

EID: 85002412764     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.309318     Document Type: Article

References (47)

1. Libby P, Ridker PM, Hansson GK, Progress and challenges in translating the biology of atherosclerosis. Nature 2011 473 317 325. doi: 10.1038/nature10146
2. Donnan GA, Fisher M, Macleod M, Davis SM, Stroke. Lancet 2008 371 1612 1623. doi: 10.1016/S0140-6736(08)60694-7
3. Rerkasem K, Rothwell PM, Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev 2011 4 CD001081
4. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE, Spence JD, Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998 339 1415 1425. doi: 10.1056/NEJM199811123392002
5. Brott TG, Hobson RW II, Howard G, CREST Investigators Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010 363 11 23. doi: 10.1056/NEJMoa0912321
6. Graebe M, Pedersen SF, Højgaard L, Kjaer A, Sillesen H, 18FDG PET and ultrasound echolucency in carotid artery plaques. JACC Cardiovasc Imaging 2010 3 289 295. doi: 10.1016/j.jcmg.2010.01.001
7. Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J, Pan H, Peto R, Potter J, Rahimi K, Rau A, Robertson S, Streifler J, Thomas D, Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet 2010 376 1074 1084. doi: 10.1016/S0140-6736(10)61197-X.
8. Kakisis JD, Avgerinos ED, Antonopoulos CN, Giannakopoulos TG, Moulakakis K, Liapis CD, The European Society for Vascular Surgery guidelines for carotid intervention: an updated independent assessment and literature review. Eur J Vasc Endovasc Surg 2012 44 238 243. doi: 10.1016/j.ejvs.2012.04.015
9. Lee RC, Feinbaum RL, Ambros V, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993 75 843 854
10. Friedman RC, Farh KK, Burge CB, Bartel DP, Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009 19 92 105. doi: 10.1101/gr.082701.108
11. Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, Van Der Meer AJ, Patick AK, Chen A, Zhou Y, Persson R, King BD, Kauppinen S, Levin AA, Hodges MR, Treatment of HCV infection by targeting microRNA. N Engl J Med 2013 368 1685 1694. doi: 10.1056/NEJMoa1209026
12. Loyer X, Vion AC, Tedgui A, Boulanger CM, Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res 2014 114 345 353. doi: 10.1161/CIRCRESAHA.113.300858
13. Kinet V, Halkein J, Dirkx E, Windt LJ, Cardiovascular extracellular microRNAs: emerging diagnostic markers and mechanisms of cell-to-cell RNA communication. Front Genet 2013 4 214. doi: 10.3389/fgene.2013.00214
14. Perisic L, Aldi S, Sun Y, Folkersen L, Razuvaev A, Roy J, Lengquist M, Åkesson S, Wheelock CE, Maegdefessel L, Gabrielsen A, Odeberg J, Hansson GK, Paulsson-Berne G, Hedin U, Gene expression signatures, pathways and networks in carotid atherosclerosis. J Intern Med 2016 279 293 308. doi: 10.1111/joim.12448
15. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW, A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995 92 1355 1374
16. Redgrave JN, Gallagher P, Lovett JK, Rothwell PM, Critical cap thickness and rupture in symptomatic carotid plaques: the oxford plaque study. Stroke 2008 39 1722 1729. doi: 10.1161/STROKEAHA.107.507988
17. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, Chan WL, Tsai WT, Chen GZ, Lee CJ, Chiu CM, Chien CH, Wu MC, Huang CY, Tsou AP, Huang HD, miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 2011 39 D163 D169. doi: 10.1093/nar/gkq1107
18. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I, A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 2006 126 1203 1217. doi: 10.1016/j.cell.2006.07.031
19. Li Y, Challagundla KB, Sun XX, Zhang Q, Dai MS, MicroRNA-130a associates with ribosomal protein L11 to suppress c-Myc expression in response to UV irradiation. Oncotarget 2015 6 1101 1114. doi: 10.18632/oncotarget.2728
20. Razuvaev A, Lund K, Roy J, Hedin U, Caidahl K, Noninvasive real-time imaging of intima thickness after rat carotid artery balloon injury using ultrasound biomicroscopy. Atherosclerosis 2008 199 310 316. doi: 10.1016/j.atherosclerosis.2007.11.035
21. Sasaki T, Kuzuya M, Nakamura K, Cheng XW, Shibata T, Sato K, Iguchi A, A simple method of plaque rupture induction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2006 26 1304 1309. doi: 10.1161/01.ATV.0000219687.71607.f7
22. Larsson M, Rayzman V, Nolte MW, A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk. Sci Transl Med 2014 6 222ra17. doi: 10.1126/scitranslmed.3006804
23. Schneikert J, Behrens J, Truncated APC is required for cell proliferation and DNA replication. Int J Cancer 2006 119 74 79. doi: 10.1002/ijc.21826
24. Weber M, Baker MB, Moore JP, Searles CD, MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem Biophys Res Commun 2010 393 643 648. doi: 10.1016/j.bbrc.2010.02.045
25. Van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN, Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 2008 105 13027 13032. doi: 10.1073/pnas.0805038105
26. Schober A, Nazari-Jahantigh M, Wei Y, Bidzhekov K, Gremse F, Grommes J, Megens RT, Heyll K, Noels H, Hristov M, Wang S, Kiessling F, Olson EN, Weber C, MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med 2014 20 368 376. doi: 10.1038/nm.3487
27. Albinsson S, Suarez Y, Skoura A, Offermanns S, Miano JM, Sessa WC, MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler Thromb Vasc Biol 2010 30 1118 1126. doi: 10.1161/ATVBAHA.109.200873
28. Fasanaro P, Greco S, Lorenzi M, Pescatori M, Brioschi M, Kulshreshtha R, Banfi C, Stubbs A, Calin GA, Ivan M, Capogrossi MC, Martelli F, An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem 2009 284 35134 35143. doi: 10.1074/jbc.M109.052779
29. Mutharasan RK, Nagpal V, Ichikawa Y, Ardehali H, microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects. Am J Physiol Heart Circ Physiol 2011 301 H1519 H1530. doi: 10.1152/ajpheart.01080.2010
30. Mill C, George SJ, Wnt signalling in smooth muscle cells and its role in cardiovascular disorders. Cardiovasc Res 2012 95 233 240. doi: 10.1093/cvr/cvs141
31. Lv L, Zhou Z, Huang X, Zhao Y, Zhang L, Shi Y, Sun M, Zhang J, Inhibition of peptidyl-prolyl cis/trans isomerase Pin1 induces cell cycle arrest and apoptosis in vascular smooth muscle cells. Apoptosis 2010 15 41 54. doi: 10.1007/s10495-009-0409-8
32. Noman MZ, Buart S, Romero P, Ketari S, Janji B, Mari B, Mami-Chouaib F, Chouaib S, Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells. Cancer Res 2012 72 4629 4641. doi: 10.1158/0008-5472.CAN-12-1383
33. Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, Loscalzo J, MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab 2009 10 273 284. doi: 10.1016/j.cmet.2009.08.015
34. Hoffman Y, Bublik DR, Ugalde AP, Elkon R, Biniashvili T, Agami R, Oren M, Pilpel Y, 3'UTR shortening potentiates microRNA-based repression of pro-differentiation genes in proliferating human cells. PLoS Genet 2016 12 e1005879. doi: 10.1371/journal.pgen.1005879
35. Shi ZD, Tarbell JM, Fluid flow mechanotransduction in vascular smooth muscle cells and fibroblasts. Ann Biomed Eng 2011 39 1608 1619. doi: 10.1007/s10439-011-0309-2
36. Ekstrand J, Razuvaev A, Folkersen L, Roy J, Hedin U, Tissue factor pathway inhibitor-2 is induced by fluid shear stress in vascular smooth muscle cells and affects cell proliferation and survival. J Vasc Surg 2010 52 167 175. doi: 10.1016/j.jvs.2010.02.282
37. Markowitz SD, Bertagnolli MM, Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 2009 361 2449 2460. doi: 10.1056/NEJMra0804588
38. Takaya N, Yuan C, Chu B, Saam T, Underhill H, Cai J, Tran N, Polissar NL, Isaac C, Ferguson MS, Garden GA, Cramer SC, Maravilla KR, Hashimoto B, Hatsukami TS, Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI-initial results. Stroke 2006 37 818 823. doi: 10.1161/01.STR.0000204638.91099.91
39. Fleg JL, Stone GW, Fayad ZA, Granada JF, Hatsukami TS, Kolodgie FD, Ohayon J, Pettigrew R, Sabatine MS, Tearney GJ, Waxman S, Domanski MJ, Srinivas PR, Narula J, Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions. JACC Cardiovasc Imaging 2012 5 941 955. doi: 10.1016/j.jcmg.2012.07.007
40. Kwekkeboom RF, Sluijter JP, Van Middelaar BJ, Metz CH, Brans MA, Kamp O, Paulus WJ, Musters RJ, Increased local delivery of antagomir therapeutics to the rodent myocardium using ultrasound and microbubbles. J Control Release 2016 222 18 31. doi: 10.1016/j.jconrel.2015.11.020
41. Small EM, Olson EN, Pervasive roles of microRNAs in cardiovascular biology. Nature 2011 469 336 342. doi: 10.1038/nature09783
42. Grosso S, Doyen J, Parks SK, Bertero T, Paye A, Cardinaud B, Gounon P, Lacas-Gervais S, Noël A, Pouysségur J, Barbry P, Mazure NM, Mari B, MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. Cell Death Dis 2013 4 e544. doi: 10.1038/cddis.2013.71
43. Qin Q, Furong W, Baosheng L, Multiple functions of hypoxia-regulated miR-210 in cancer. J Exp Clin Cancer Res 2014 33 50. doi: 10.1186/1756-9966-33-50
44. Wang D, Deuse T, Stubbendorff M, Local microRNA modulation using a novel anti-miR-21-eluting stent effectively prevents experimental in-stent restenosis. Arterioscler Thromb Vasc Biol 2015 35 1945 1953. doi: 10.1161/ATVBAHA.115.305597
45. Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan MA, Fasanaro P, Sun N, Wang X, Martelli F, Robbins RC, Wu JC, MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 2010 122 S124 S131. doi: 10.1161/CIRCULATIONAHA.109.928424
46. Slager CJ, Wentzel JJ, Gijsen FJ, Thury A, Van Der Wal AC, Schaar JA, Serruys PW, The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications. Nat Clin Pract Cardiovasc Med 2005 2 456 464. doi: 10.1038/ncpcardio0298
47. Conway DE, Schwartz MA, Flow-dependent cellular mechanotransduction in atherosclerosis. J Cell Sci 2013 126 5101 5109. doi: 10.1242/jcs.138313